Exozymes Inc. logo

Exozymes Inc. (EXOZ)

Market Open
16 Jun, 17:10
NASDAQ (CM) NASDAQ (CM)
$
7. 58
+0.23
+3.1293%
$
65.46M Market Cap
- P/E Ratio
- Div Yield
883 Volume
- Eps
$ 7.35
Previous Close
Add Transaction
Day Range
7.36 7.79
Year Range
7.08 18.4
Want to track EXOZ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

EXOZ trading today higher at $7.58, an increase of 3.1293% from yesterday's close, completing a monthly decrease of -20.5867% or -$1.96. Over the past 12 months, EXOZ stock lost -31.2534%.
EXOZ is not paying dividends to its shareholders.
The last earnings report, released on Mar 30, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

EXOZ Chart

People also search for

Benitec Biopharma Inc.
$ 11.06
-2.3822%
Palisade Bio Inc.
$ 1.71
+1.1598%
Nuvectis Pharma Inc.
$ 11.91
+6.843%
Compass Therapeutics Inc.
$ 2
-2.2059%
Elicio Therapeutics Inc.
$ 2.85
-30.1471%

Exozymes Inc. (EXOZ) FAQ

What is the stock price today?

The current price is $7.58.

On which exchange is it traded?

Exozymes Inc. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is EXOZ.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 65.46M.

Has Exozymes Inc. ever had a stock split?

No, there has never been a stock split.

Exozymes Inc. Profile

Biotechnology Industry
Healthcare Sector
Michael Heltzen CEO
NASDAQ (CM) Exchange
461874109 CUSIP
US Country
31 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

eXoZymes, Inc. is a pioneering synthetic biochemical company situated in the United States, specifically in Monrovia, California. Since its inception in 2014, the company has dedicated itself to the innovative development of biocatalytic technologies. At the core of its operations is SimplePath, a versatile platform that enables the production of a wide range of chemicals, including pharmaceuticals, fuels, materials, food additives, and unique compounds. By employing advanced enzymatic processes, eXoZymes is at the forefront of creating sustainable solutions that cater to various industrial needs.

Products and Services

  • SimplePath Platform

    The SimplePath platform serves as the foundation of eXoZymes’ operations, leveraging advanced biocatalytic processes to convert raw materials into high-value chemicals. This modular platform is designed to be adaptable, with different enzymes working in concert to achieve specific biochemical transformations efficiently.

  • Pharmaceuticals

    eXoZymes produces a variety of pharmaceutical compounds utilizing its enzyme-driven processes. This allows for the production of active ingredients that can enhance drug efficacy while minimizing environmental impact, ultimately contributing to more sustainable healthcare solutions.

  • Fuels

    The company’s technology also extends to the production of biofuels. By utilizing biocatalysis, eXoZymes aims to create sustainable alternatives to conventional fossil fuels, thereby reducing carbon footprints and supporting eco-friendly energy transitions.

  • Materials

    In the materials sector, eXoZymes develops biochemically-derived materials that can be employed in various applications. These materials not only meet performance standards but also align with sustainability goals, catering to industries seeking greener options.

  • Food Additives

    eXoZymes also focuses on the food industry by creating innovative food additives. Through biocatalytic conversion, these additives enhance flavor, preservation, and nutritional value, all while adhering to safety and regulatory standards.

  • Novel Compounds

    Lastly, the company is involved in developing novel compounds that may have applications across multiple sectors, driving research and innovation that can lead to breakthroughs in technology and consumer products.

Contact Information

Address: 750 Royal Oaks Drive
Phone: 626 415 1488